Serious cardiovascular events were rare MS patients receiving high-efficacy disease modifying treatments

Best Practice Nordic | Sept 2019 | ECTRIMS 2019 |

MS patients have a generally increased risk of cardiovascular disease, but there is little data on how different disease modifying treatments may alter this risk in patients treated in clinical practice. In this MEDtalk Thomas Frisell will give you an answer.